Truist Financial and Needham & Company raised the price objective and issued a buy rating for MACOM Technology Solutions Holdings.
1 report, 1 independent
Updated Jun 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial and Needham & Company raised the price objective and issued a buy rating for MACOM Technology Solutions Holdings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Truist Financial issued a 'buy' rating and lifted the price objective for James Hardie on August 18, 2026.
- Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
- Multiple financial firms, including Keefe, Bruyette & Woods, Jefferies, and TD Cowen, adjusted price targets and ratings on September 24, 2026.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Needham & Company cut its price target and set a buy rating for Endava, while CLSA also set a $5.00 price objective.